Rankings
▼
Calendar
PLSE FY 2024 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
FY 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$56M
Net Income
-$54M
EPS (Diluted)
$-0.92
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$132M
Total Liabilities
$18M
Stockholders' Equity
$115M
Cash & Equivalents
$118M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$1M
+100.0%
Operating Income
-$56M
-$44M
-29.1%
Net Income
-$54M
-$42M
-26.9%
← Q4 2023
All Quarters
Q1 2024 →